Protective role of wogonin against lipopolysaccharide-induced angiogenesis via VEGFR-2, not VEGFR-1

Chiu Mei Lin, Hang Chang, Yeh Hsu Chen, Shih Yun Li, I. Hsing Wu, Jen Hwey Chiu

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

Wogonin, one of flavonoid derived from particular plants, enriches the property of anti-inflammation. Inflammation-stimulated angiogenesis plays an important role in many pathological diseases, such as rheumatoid arthritis, atherosclerosis, and cancer. The aim of this study was to investigate the suppressive effect of wogonin on lipopolysaccharide (LPS)-induced angiogenesis in human umbilical endothelial cell (HUVEC) cultures. By cell differentiation assays, migration and tube formation activity under LPS treatment were evaluated. Besides, IL-6 neutralizing antibody was added to test the inhibitory effect in the phenotypic alteration. Western blot analysis, ELISA cytokine assay, and quantitative real time-PCR were performed for VEGF, IL-6, VEGF receptors, and IL-6 receptor gene expressions on HUVEC with wogonin treatment. Furthermore, in vivo chorioallantoic membrane (CAM) assay was applied to evaluate the percentage of new vessels formation. The results revealed that wogonin (10- 8-10- 5 M) inhibited LPS-induced angiogenesis in a concentration-dependent manner. The mRNA and protein expressions of VEGF, VEGFR-2, IL-6, and sIL-6Rα were attenuated (P <0.05), but not VEGFR-1. In the LPS-induced CAM model, our data suggested that wogonin (10- 8-10- 5 M) significantly decreased new vessel formation and vascular network (P <0.05). We conclude that wogonin suppresses both in vitro and in vivo LPS-induced angiogenesis, through VEGFR-2, but not VEGFR-1.

Original languageEnglish
Pages (from-to)1690-1698
Number of pages9
JournalInternational Immunopharmacology
Volume6
Issue number11
DOIs
Publication statusPublished - Nov 2006

Fingerprint

Vascular Endothelial Growth Factor Receptor-1
Vascular Endothelial Growth Factor Receptor-2
Lipopolysaccharides
Interleukin-6 Receptors
Chorioallantoic Membrane
Vascular Endothelial Growth Factor A
Interleukin-6
Inflammation
Umbilicus
Vascular Endothelial Growth Factor Receptor
Neutralizing Antibodies
Flavonoids
Blood Vessels
wogonin
Real-Time Polymerase Chain Reaction
Cell Differentiation
Rheumatoid Arthritis
Atherosclerosis
Endothelial Cells
Cell Culture Techniques

Keywords

  • IL-6
  • Lipopolysaccharide
  • VEGF
  • VEGFR-2
  • Wogonin

ASJC Scopus subject areas

  • Immunology
  • Pharmacology

Cite this

Protective role of wogonin against lipopolysaccharide-induced angiogenesis via VEGFR-2, not VEGFR-1. / Lin, Chiu Mei; Chang, Hang; Chen, Yeh Hsu; Li, Shih Yun; Wu, I. Hsing; Chiu, Jen Hwey.

In: International Immunopharmacology, Vol. 6, No. 11, 11.2006, p. 1690-1698.

Research output: Contribution to journalArticle

Lin, Chiu Mei ; Chang, Hang ; Chen, Yeh Hsu ; Li, Shih Yun ; Wu, I. Hsing ; Chiu, Jen Hwey. / Protective role of wogonin against lipopolysaccharide-induced angiogenesis via VEGFR-2, not VEGFR-1. In: International Immunopharmacology. 2006 ; Vol. 6, No. 11. pp. 1690-1698.
@article{3a461aba868c40a794d9c65e5a08881f,
title = "Protective role of wogonin against lipopolysaccharide-induced angiogenesis via VEGFR-2, not VEGFR-1",
abstract = "Wogonin, one of flavonoid derived from particular plants, enriches the property of anti-inflammation. Inflammation-stimulated angiogenesis plays an important role in many pathological diseases, such as rheumatoid arthritis, atherosclerosis, and cancer. The aim of this study was to investigate the suppressive effect of wogonin on lipopolysaccharide (LPS)-induced angiogenesis in human umbilical endothelial cell (HUVEC) cultures. By cell differentiation assays, migration and tube formation activity under LPS treatment were evaluated. Besides, IL-6 neutralizing antibody was added to test the inhibitory effect in the phenotypic alteration. Western blot analysis, ELISA cytokine assay, and quantitative real time-PCR were performed for VEGF, IL-6, VEGF receptors, and IL-6 receptor gene expressions on HUVEC with wogonin treatment. Furthermore, in vivo chorioallantoic membrane (CAM) assay was applied to evaluate the percentage of new vessels formation. The results revealed that wogonin (10- 8-10- 5 M) inhibited LPS-induced angiogenesis in a concentration-dependent manner. The mRNA and protein expressions of VEGF, VEGFR-2, IL-6, and sIL-6Rα were attenuated (P <0.05), but not VEGFR-1. In the LPS-induced CAM model, our data suggested that wogonin (10- 8-10- 5 M) significantly decreased new vessel formation and vascular network (P <0.05). We conclude that wogonin suppresses both in vitro and in vivo LPS-induced angiogenesis, through VEGFR-2, but not VEGFR-1.",
keywords = "IL-6, Lipopolysaccharide, VEGF, VEGFR-2, Wogonin",
author = "Lin, {Chiu Mei} and Hang Chang and Chen, {Yeh Hsu} and Li, {Shih Yun} and Wu, {I. Hsing} and Chiu, {Jen Hwey}",
year = "2006",
month = "11",
doi = "10.1016/j.intimp.2006.07.003",
language = "English",
volume = "6",
pages = "1690--1698",
journal = "International Immunopharmacology",
issn = "1567-5769",
publisher = "Elsevier",
number = "11",

}

TY - JOUR

T1 - Protective role of wogonin against lipopolysaccharide-induced angiogenesis via VEGFR-2, not VEGFR-1

AU - Lin, Chiu Mei

AU - Chang, Hang

AU - Chen, Yeh Hsu

AU - Li, Shih Yun

AU - Wu, I. Hsing

AU - Chiu, Jen Hwey

PY - 2006/11

Y1 - 2006/11

N2 - Wogonin, one of flavonoid derived from particular plants, enriches the property of anti-inflammation. Inflammation-stimulated angiogenesis plays an important role in many pathological diseases, such as rheumatoid arthritis, atherosclerosis, and cancer. The aim of this study was to investigate the suppressive effect of wogonin on lipopolysaccharide (LPS)-induced angiogenesis in human umbilical endothelial cell (HUVEC) cultures. By cell differentiation assays, migration and tube formation activity under LPS treatment were evaluated. Besides, IL-6 neutralizing antibody was added to test the inhibitory effect in the phenotypic alteration. Western blot analysis, ELISA cytokine assay, and quantitative real time-PCR were performed for VEGF, IL-6, VEGF receptors, and IL-6 receptor gene expressions on HUVEC with wogonin treatment. Furthermore, in vivo chorioallantoic membrane (CAM) assay was applied to evaluate the percentage of new vessels formation. The results revealed that wogonin (10- 8-10- 5 M) inhibited LPS-induced angiogenesis in a concentration-dependent manner. The mRNA and protein expressions of VEGF, VEGFR-2, IL-6, and sIL-6Rα were attenuated (P <0.05), but not VEGFR-1. In the LPS-induced CAM model, our data suggested that wogonin (10- 8-10- 5 M) significantly decreased new vessel formation and vascular network (P <0.05). We conclude that wogonin suppresses both in vitro and in vivo LPS-induced angiogenesis, through VEGFR-2, but not VEGFR-1.

AB - Wogonin, one of flavonoid derived from particular plants, enriches the property of anti-inflammation. Inflammation-stimulated angiogenesis plays an important role in many pathological diseases, such as rheumatoid arthritis, atherosclerosis, and cancer. The aim of this study was to investigate the suppressive effect of wogonin on lipopolysaccharide (LPS)-induced angiogenesis in human umbilical endothelial cell (HUVEC) cultures. By cell differentiation assays, migration and tube formation activity under LPS treatment were evaluated. Besides, IL-6 neutralizing antibody was added to test the inhibitory effect in the phenotypic alteration. Western blot analysis, ELISA cytokine assay, and quantitative real time-PCR were performed for VEGF, IL-6, VEGF receptors, and IL-6 receptor gene expressions on HUVEC with wogonin treatment. Furthermore, in vivo chorioallantoic membrane (CAM) assay was applied to evaluate the percentage of new vessels formation. The results revealed that wogonin (10- 8-10- 5 M) inhibited LPS-induced angiogenesis in a concentration-dependent manner. The mRNA and protein expressions of VEGF, VEGFR-2, IL-6, and sIL-6Rα were attenuated (P <0.05), but not VEGFR-1. In the LPS-induced CAM model, our data suggested that wogonin (10- 8-10- 5 M) significantly decreased new vessel formation and vascular network (P <0.05). We conclude that wogonin suppresses both in vitro and in vivo LPS-induced angiogenesis, through VEGFR-2, but not VEGFR-1.

KW - IL-6

KW - Lipopolysaccharide

KW - VEGF

KW - VEGFR-2

KW - Wogonin

UR - http://www.scopus.com/inward/record.url?scp=33748421494&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748421494&partnerID=8YFLogxK

U2 - 10.1016/j.intimp.2006.07.003

DO - 10.1016/j.intimp.2006.07.003

M3 - Article

C2 - 16979123

AN - SCOPUS:33748421494

VL - 6

SP - 1690

EP - 1698

JO - International Immunopharmacology

JF - International Immunopharmacology

SN - 1567-5769

IS - 11

ER -